Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Subscribe

Logo for

Science 301 (5634): 839-842

Copyright © 2003 by the American Association for the Advancement of Science

Retrograde Viral Delivery of IGF-1 Prolongs Survival in a Mouse ALS Model

Brian K. Kaspar,1 Jerònia Lladó,2* Nushin Sherkat,1 Jeffrey D. Rothstein,2 Fred H. Gage1{dagger}

Abstract: Amyotrophic lateral sclerosis (ALS) is a progressive, lethal neuromuscular disease that is associated with the degeneration of spinal and brainstem motor neurons, leading to atrophy of limb, axial, and respiratory muscles. The cause of ALS is unknown, and there is no effective therapy. Neurotrophic factors are candidates for therapeutic evaluation in ALS. Although chronic delivery of molecules to the central nervous system has proven difficult, we recently discovered that adeno-associated virus can be retrogradely transported efficiently from muscle to motor neurons of the spinal cord. We report that insulin-like growth factor 1 prolongs life and delays disease progression, even when delivered at the time of overt disease symptoms.

1 Laboratory of Genetics, The Salk Institute for Biological Studies, La Jolla, CA 92037, USA.
2 Departments of Neurology and Neuroscience, Johns Hopkins University, 600 North Wolfe Street, Meyer 6-109, Baltimore, MD 21287, USA.

Back to Top

* Present address: Institut Universitari d'Investigació en Ciències de la Salut (IUNICS), Hospital Son Dureta, C/Andrea Doria 55, Edifici D 1a planta, 07014 Palma, Illes Balears, Spain.

{dagger} To whom correspondence should be addressed. E-mail: gage{at}salk.edu


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Polyethylene glycol-coupled IGF1 delays motor function defects in a mouse model of spinal muscular atrophy with respiratory distress type 1.
F. Krieger, N. Elflein, S. Saenger, E. Wirthgen, K. Rak, S. Frantz, A. Hoeflich, K. V. Toyka, F. Metzger, and S. Jablonka (2014)
Brain
   Abstract »    Full Text »    PDF »
Adeno-Associated Virus Vectors and Neurological Gene Therapy.
D. S. Ojala, D. P. Amara, and D. V. Schaffer (2014)
Neuroscientist
   Abstract »    Full Text »    PDF »
Widespread spinal cord transduction by intrathecal injection of rAAV delivers efficacious RNAi therapy for amyotrophic lateral sclerosis.
H. Wang, B. Yang, L. Qiu, C. Yang, J. Kramer, Q. Su, Y. Guo, R. H. Brown Jr, G. Gao, and Z. Xu (2014)
Hum. Mol. Genet. 23, 668-681
   Abstract »    Full Text »    PDF »
MEAT SCIENCE AND MUSCLE BIOLOGY SYMPOSIUM--Role of satellite cells in anabolic steroid-induced muscle growth in feedlot steers.
W. R. Dayton and M. E. White (2014)
J Anim Sci 92, 30-38
   Abstract »    Full Text »    PDF »
Subventricular Zone-Derived Neural Stem Cell Grafts Protect Against Hippocampal Degeneration and Restore Cognitive Function in the Mouse Following Intrahippocampal Kainic Acid Administration.
P. Miltiadous, G. Kouroupi, A. Stamatakis, P. N. Koutsoudaki, R. Matsas, and F. Stylianopoulou (2013)
Stem Cells Trans Med 2, 185-198
   Abstract »    Full Text »    PDF »
Myelin Loss Does Not Lead to Axonal Degeneration in a Long-Lived Model of Chronic Demyelination.
C. M. Smith, E. Cooksey, and I. D. Duncan (2013)
J. Neurosci. 33, 2718-2727
   Abstract »    Full Text »    PDF »
Multimodal Actions of Neural Stem Cells in a Mouse Model of ALS: A Meta-Analysis.
Y. D. Teng, S. C. Benn, S. N. Kalkanis, J. M. Shefner, R. C. Onario, B. Cheng, M. B. Lachyankar, M. Marconi, J. Li, D. Yu, et al. (2012)
Science Translational Medicine 4, 165ra164
   Abstract »    Full Text »    PDF »
Upregulation of the E3 ligase NEDD4-1 by Oxidative Stress Degrades IGF-1 Receptor Protein in Neurodegeneration.
Y.-D. Kwak, B. Wang, J. J. Li, R. Wang, Q. Deng, S. Diao, Y. Chen, R. Xu, E. Masliah, H. Xu, et al. (2012)
J. Neurosci. 32, 10971-10981
   Abstract »    Full Text »    PDF »
Human Axonal Survival of Motor Neuron (a-SMN) Protein Stimulates Axon Growth, Cell Motility, C-C Motif Ligand 2 (CCL2), and Insulin-like Growth Factor-1 (IGF1) Production.
D. Locatelli, M. Terao, M. Fratelli, A. Zanetti, M. Kurosaki, M. Lupi, M. M. Barzago, A. Uggetti, S. Capra, P. D'Errico, et al. (2012)
J. Biol. Chem. 287, 25782-25794
   Abstract »    Full Text »    PDF »
The in vivo contribution of motor neuron TrkB receptors to mutant SOD1 motor neuron disease.
J. Zhai, W. Zhou, J. Li, C. R. Hayworth, L. Zhang, H. Misawa, R. Klein, S. S. Scherer, R. J. Balice-Gordon, and R. G. Kalb (2011)
Hum. Mol. Genet. 20, 4116-4131
   Abstract »    Full Text »    PDF »
Increased IGF-1 in muscle modulates the phenotype of severe SMA mice.
M. Bosch-Marce, C. D. Wee, T. L. Martinez, C. E. Lipkes, D. W. Choe, L. Kong, J. P. Van Meerbeke, A. Musaro, and C. J. Sumner (2011)
Hum. Mol. Genet. 20, 1844-1853
   Abstract »    Full Text »    PDF »
Genetic therapy for the nervous system.
W. J. Bowers, X. O. Breakefield, and M. Sena-Esteves (2011)
Hum. Mol. Genet. 20, R28-R41
   Abstract »    Full Text »    PDF »
Global gene expression profiling of somatic motor neuron populations with different vulnerability identify molecules and pathways of degeneration and protection.
E. Hedlund, M. Karlsson, T. Osborn, W. Ludwig, and O. Isacson (2010)
Brain 133, 2313-2330
   Abstract »    Full Text »    PDF »
Collapsin Response Mediator Protein 4a (CRMP4a) Is Upregulated in Motoneurons of Mutant SOD1 Mice and Can Trigger Motoneuron Axonal Degeneration and Cell Death.
L. Duplan, N. Bernard, W. Casseron, K. Dudley, E. Thouvenot, J. Honnorat, V. Rogemond, B. De Bovis, P. Aebischer, P. Marin, et al. (2010)
J. Neurosci. 30, 785-796
   Abstract »    Full Text »    PDF »
Role and Therapeutic Potential of VEGF in the Nervous System.
C. Ruiz de Almodovar, D. Lambrechts, M. Mazzone, and P. Carmeliet (2009)
Physiol Rev 89, 607-648
   Abstract »    Full Text »    PDF »
Schwann cells expressing dismutase active mutant SOD1 unexpectedly slow disease progression in ALS mice.
C. S. Lobsiger, S. Boillee, M. McAlonis-Downes, A. M. Khan, M. L. Feltri, K. Yamanaka, and D. W. Cleveland (2009)
PNAS 106, 4465-4470
   Abstract »    Full Text »    PDF »
Delivery of recombinant follistatin lessens disease severity in a mouse model of spinal muscular atrophy.
F. F. Rose Jr, V. B. Mattis, H. Rindt, and C. L. Lorson (2009)
Hum. Mol. Genet. 18, 997-1005
   Abstract »    Full Text »    PDF »
Efficient gene therapy-based method for the delivery of therapeutics to primate cortex.
A. P. Kells, P. Hadaczek, D. Yin, J. Bringas, V. Varenika, J. Forsayeth, and K. S. Bankiewicz (2009)
PNAS 106, 2407-2411
   Abstract »    Full Text »    PDF »
Granulocyte-colony stimulating factor improves outcome in a mouse model of amyotrophic lateral sclerosis.
C. Pitzer, C. Kruger, C. Plaas, F. Kirsch, T. Dittgen, R. Muller, R. Laage, S. Kastner, S. Suess, R. Spoelgen, et al. (2008)
Brain 131, 3335-3347
   Abstract »    Full Text »    PDF »
T lymphocytes potentiate endogenous neuroprotective inflammation in a mouse model of ALS.
I. M. Chiu, A. Chen, Y. Zheng, B. Kosaras, S. A. Tsiftsoglou, T. K. Vartanian, R. H. Brown Jr, and M. C. Carroll (2008)
PNAS 105, 17913-17918
   Abstract »    Full Text »    PDF »
IGFBP-5 regulates muscle cell differentiation by binding to IGF-II and switching on the IGF-II auto-regulation loop.
H. Ren, P. Yin, and C. Duan (2008)
J. Cell Biol. 182, 979-991
   Abstract »    Full Text »    PDF »
Mesenchymal stromal cells genetically engineered to overexpress IGF-I enhance cell-based gene therapy of renal failure-induced anemia.
T. Kucic, I. B. Copland, J. Cuerquis, D. L. Coutu, L. E. Chalifour, R. F. Gagnon, and J. Galipeau (2008)
Am J Physiol Renal Physiol 295, F488-F496
   Abstract »    Full Text »    PDF »
Mutant SOD1 in cell types other than motor neurons and oligodendrocytes accelerates onset of disease in ALS mice.
K. Yamanaka, S. Boillee, E. A. Roberts, M. L. Garcia, M. McAlonis-Downes, O. R. Mikse, D. W. Cleveland, and L. S. B. Goldstein (2008)
PNAS 105, 7594-7599
   Abstract »    Full Text »    PDF »
Adeno-Associated Virus Transfer of a Gene Encoding SNAP-25 Resistant to Botulinum Toxin A Attenuates Neuromuscular Paralysis Associated with Botulism.
A. Raghunath, F. Perez-Branguli, L. Smith, and J. O. Dolly (2008)
J. Neurosci. 28, 3683-3688
   Abstract »    Full Text »    PDF »
The Neurotrophic Effects of Glial Cell Line-Derived Neurotrophic Factor on Spinal Motoneurons Are Restricted to Fusimotor Subtypes.
T. W. Gould, S. Yonemura, R. W. Oppenheim, S. Ohmori, and H. Enomoto (2008)
J. Neurosci. 28, 2131-2146
   Abstract »    Full Text »    PDF »
Neurodegeneration and cell replacement.
B. K Ormerod, T. D Palmer, and M. A Caldwell (2008)
Phil Trans R Soc B 363, 153-170
   Abstract »    Full Text »    PDF »
Exogenous Delivery of Heat Shock Protein 70 Increases Lifespan in a Mouse Model of Amyotrophic Lateral Sclerosis.
D. J. Gifondorwa, M. B. Robinson, C. D. Hayes, A. R. Taylor, D. M. Prevette, R. W. Oppenheim, J. Caress, and C. E. Milligan (2007)
J. Neurosci. 27, 13173-13180
   Abstract »    Full Text »    PDF »
A Single Injection of an Adeno-Associated Virus Vector into Nuclei with Divergent Connections Results in Widespread Vector Distribution in the Brain and Global Correction of a Neurogenetic Disease.
C. N. Cearley and J. H. Wolfe (2007)
J. Neurosci. 27, 9928-9940
   Abstract »    Full Text »    PDF »
What is next in ALS clinical trials?.
E. J. Sorenson (2007)
Neurology 69, 719-720
   Full Text »    PDF »
Interaction between Familial Amyotrophic Lateral Sclerosis (ALS)-linked SOD1 Mutants and the Dynein Complex.
F. Zhang, A.-L. Strom, K. Fukada, S. Lee, L. J. Hayward, and H. Zhu (2007)
J. Biol. Chem. 282, 16691-16699
   Abstract »    Full Text »    PDF »
Concurrent Administration of Neu2000 and Lithium Produces Marked Improvement of Motor Neuron Survival, Motor Function, and Mortality in a Mouse Model of Amyotrophic Lateral Sclerosis.
J. H. Shin, S. I. Cho, H. R. Lim, J. K. Lee, Y. A. Lee, J. S. Noh, I. S. Joo, K.-W. Kim, and B. J. Gwag (2007)
Mol. Pharmacol. 71, 965-975
   Abstract »    Full Text »    PDF »
PACAP type I receptor transactivation is essential for IGF-1 receptor signalling and antiapoptotic activity in neurons.
N. Delcourt, E. Thouvenot, B. Chanrion, N. Galeotti, P. Jouin, J. Bockaert, and P. Marin (2007)
EMBO J. 26, 1542-1551
   Abstract »    Full Text »    PDF »
Cortical area size dictates performance at modality-specific behaviors.
A. Leingartner, S. Thuret, T. T. Kroll, S.-J. Chou, J. L. Leasure, F. H. Gage, and D. D. M. O'Leary (2007)
PNAS 104, 4153-4158
   Abstract »    Full Text »    PDF »
Respiratory impairment in a mouse model of amyotrophic lateral sclerosis.
C. G. Tankersley, C. Haenggeli, and J. D. Rothstein (2007)
J Appl Physiol 102, 926-932
   Abstract »    Full Text »    PDF »
Therapeutic effects of immunization with mutant superoxide dismutase in mice models of amyotrophic lateral sclerosis.
M. Urushitani, S. A. Ezzi, and J.-P. Julien (2007)
PNAS 104, 2495-2500
   Abstract »    Full Text »    PDF »
Gene transfer demonstrates that muscle is not a primary target for non-cell-autonomous toxicity in familial amyotrophic lateral sclerosis.
T. M. Miller, S. H. Kim, K. Yamanaka, M. Hester, P. Umapathi, H. Arnson, L. Rizo, J. R. Mendell, F. H. Gage, D. W. Cleveland, et al. (2006)
PNAS 103, 19546-19551
   Abstract »    Full Text »    PDF »
The neurite outgrowth inhibitor Nogo-A promotes denervation in an amyotrophic lateral sclerosis model.
N. Jokic, J.-L. Gonzalez de Aguilar, L. Dimou, S. Lin, A. Fergani, M. A. Ruegg, M. E. Schwab, L. Dupuis, and J.-P. Loeffler (2006)
EMBO Rep. 7, 1162-1167
   Abstract »    Full Text »    PDF »
Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis.
D. R. Beers, J. S. Henkel, Q. Xiao, W. Zhao, J. Wang, A. A. Yen, L. Siklos, S. R. McKercher, and S. H. Appel (2006)
PNAS 103, 16021-16026
   Abstract »    Full Text »    PDF »
The inflammatory NADPH oxidase enzyme modulates motor neuron degeneration in amyotrophic lateral sclerosis mice.
D.-C. Wu, D. B. Re, M. Nagai, H. Ischiropoulos, and S. Przedborski (2006)
PNAS 103, 12132-12137
   Abstract »    Full Text »    PDF »
Neuroprotective agents for clinical trials in ALS: A systematic assessment..
B. J. Traynor, L. Bruijn, R. Conwit, F. Beal, G. O'Neill, S. C. Fagan, and M. E. Cudkowicz (2006)
Neurology 67, 20-27
   Abstract »    Full Text »    PDF »
Informatics-assisted Protein Profiling in a Transgenic Mouse Model of Amyotrophic Lateral Sclerosis.
T. J. Lukas, W. W. Luo, H. Mao, N. Cole, and T. Siddique (2006)
Mol. Cell. Proteomics 5, 1233-1244
   Abstract »    Full Text »    PDF »
Als2-deficient mice exhibit disturbances in endosome trafficking associated with motor behavioral abnormalities.
R. S. Devon, P. C. Orban, K. Gerrow, M. A. Barbieri, C. Schwab, L. P. Cao, J. R. Helm, N. Bissada, R. Cruz-Aguado, T.-L. Davidson, et al. (2006)
PNAS 103, 9595-9600
   Abstract »    Full Text »    PDF »
Risks, benefits, and consent in the age of gene therapy.
J. R. Mendell and K. R. Clark (2006)
Neurology 66, 964-965
   Full Text »    PDF »
Autophagy-mediated clearance of huntingtin aggregates triggered by the insulin-signaling pathway.
A. Yamamoto, M. L. Cremona, and J. E. Rothman (2006)
J. Cell Biol. 172, 719-731
   Abstract »    Full Text »    PDF »
Intracranial Delivery of CLN2 Reduces Brain Pathology in a Mouse Model of Classical Late Infantile Neuronal Ceroid Lipofuscinosis.
M. A. Passini, J. C. Dodge, J. Bu, W. Yang, Q. Zhao, D. Sondhi, N. R. Hackett, S. M. Kaminsky, Q. Mao, L. S. Shihabuddin, et al. (2006)
J. Neurosci. 26, 1334-1342
   Abstract »    Full Text »    PDF »
Intraneuronal {beta}-Amyloid Expression Downregulates the Akt Survival Pathway and Blunts the Stress Response.
J. Magrane, K. M. Rosen, R. C. Smith, K. Walsh, G. K. Gouras, and H. W. Querfurth (2005)
J. Neurosci. 25, 10960-10969
   Abstract »    Full Text »    PDF »
No widespread induction of cell death genes occurs in pure motoneurons in an amyotrophic lateral sclerosis mouse model.
F. E. Perrin, G. Boisset, M. Docquier, O. Schaad, P. Descombes, and A. C. Kato (2005)
Hum. Mol. Genet. 14, 3309-3320
   Abstract »    Full Text »    PDF »
Amelioration of laminin-{alpha}2-deficient congenital muscular dystrophy by somatic gene transfer of miniagrin.
C. Qiao, J. Li, T. Zhu, R. Draviam, S. Watkins, X. Ye, C. Chen, J. Li, and X. Xiao (2005)
PNAS 102, 11999-12004
   Abstract »    Full Text »    PDF »
A Rac1/Phosphatidylinositol 3-Kinase/Akt3 Anti-apoptotic Pathway, Triggered by AlsinLF, the Product of the ALS2 Gene, Antagonizes Cu/Zn-superoxide Dismutase (SOD1) Mutant-induced Motoneuronal Cell Death.
K. Kanekura, Y. Hashimoto, Y. Kita, J. Sasabe, S. Aiso, I. Nishimoto, and M. Matsuoka (2005)
J. Biol. Chem. 280, 4532-4543
   Abstract »    Full Text »    PDF »
Muscle expression of a local Igf-1 isoform protects motor neurons in an ALS mouse model.
G. Dobrowolny, C. Giacinti, L. Pelosi, C. Nicoletti, N. Winn, L. Barberi, M. Molinaro, N. Rosenthal, and A. Musaro (2005)
J. Cell Biol. 168, 193-199
   Abstract »    Full Text »    PDF »
Gene transfer for neurologic disease: Agencies, policies, and process.
J. R. Mendell and A. Miller (2004)
Neurology 63, 2225-2232
   Abstract »    Full Text »    PDF »
Role of Exogenous and Endogenous Trophic Factors in the Regulation of Extraocular Muscle Strength during Development.
J. Chen and C. S. von Bartheld (2004)
Invest. Ophthalmol. Vis. Sci. 45, 3538-3545
   Abstract »    Full Text »    PDF »
Mechanisms of Growth Hormone (GH) Action: IDENTIFICATION OF CONSERVED Stat5 BINDING SITES THAT MEDIATE GH-INDUCED INSULIN-LIKE GROWTH FACTOR-I GENE ACTIVATION.
J. Woelfle, D. J. Chia, and P. Rotwein (2003)
J. Biol. Chem. 278, 51261-51266
   Abstract »    Full Text »    PDF »

To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882